疫苗是对健康人进行接种使其产生免疫力,因此疫苗成为人类预防疾病最有效的武器而愈发受到关注。中国是全球最大的疫苗生产国,也是世界上疫苗产品生产企业最多的国家,据统计,2008年,全球疫苗生产规模达到192亿美元,并有望在2013年增长至390亿美元。面对巨大的可持续增长市场空间,对致力于这一领域的企业来说,这意味着巨大的利润增长空间。因此,此时,国内疫苗行业巨头---重庆智飞生物制品股份有限公司登陆资本市场正当时。 Vaccination is the immunization of healthy people to make them immune. Therefore, vaccines have become the most effective weapons for humans to prevent diseases and have received increasing attention. China is the world’s largest vaccine producer and the world’s largest producer of vaccine products. According to statistics, in 2008, the global vaccine production scale reached 19.2 billion U.S. dollars, and it is expected to grow to 39 billion U.S. dollars in 2013. In the face of a huge market for sustainable growth, this means huge room for profit growth for companies working in this field. Therefore, at this time, Chongqing Zhifei Biological Products Co., Ltd., the giant of the domestic vaccine industry, entered the capital market.